Search Results
MedRN: Leukemia (Topic)

274 Total downloads

Viewing: 1 - 18 of 18 papers

1.
Downloads 76
2.

Integrated High-Throughput Screen to Identify Novel Treatment Leads for Pediatric Acute Myeloid Leukemia

Number of pages: 74 Posted: 05 Apr 2018
Working Paper Series
Ohio State University (OSU) - Division of Pharmaceutics, St Jude Children’s Research Hospital - Department of Chemical Biology and Therapeutics, Ohio State University (OSU) - The James Comprehensive Cancer Center, Ohio State University (OSU) - Division of Pharmaceutics, Ohio State University (OSU) - Division of Pharmaceutics, Ohio State University (OSU) - Division of Pharmaceutics, Ohio State University (OSU) - Division of Pharmaceutics, Ohio State University (OSU) - Division of Pharmaceutics, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Oncology, University of Kentucky - Division of Pharmaceutical Sciences and Ohio State University (OSU) - Division of Pharmaceutics
Downloads 44
3.

HOTTIP lncRNA Promotes Hematopoietic Stem Cell Self-Renewal Leading to AML-Like Disease in Mice

Number of pages: 61 Posted: 31 Oct 2018
Working Paper Series
Penn State College of Medicine, University of Miami Miller School of Medicine, Xiamen University, University of Florida, University of Miami - Department of Biochemistry & Molecular Biology, Baylor University - Department of Molecular and Cellular Biology, Penn State University College of Medicine, Xiamen University, Baylor University - Department of Molecular and Cellular Biology, University of Miami, University of Florida, University of Florida, University of Miami Miller School of Medicine and Penn State University College of Medicine
Downloads 42
4.

IDH1 Mutation Enhances Catabolic Flexibility and Mitochondrial Dependencies to Favor Drug Resistance in Acute Myeloid Leukemia

Number of pages: 69 Posted: 18 Jan 2019
Working Paper Series
University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), National Infrastructure of Metabolomics and Fluxomics - MetaToul-MetaboHUB, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), Aix-Marseille University - Institut Paoli-Calmettes, MetaboHUB-Paris - Laboratoire d’Etude du Métabolisme des Médicaments, Proteome and Genome Reserch Unit, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Montpellier - Institute for Cancer Research in Montpellier, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Bordeaux - Fruit Biology and Pathology, University of Toulouse 1 - Toxalim INRA laboratory, University of Montpellier - Institute for Cancer Research in Montpellier, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Montpellier - Institute for Cancer Research in Montpellier, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), MetaboHUB-Paris - Laboratoire d’Etude du Métabolisme des Médicaments, University of Montpellier - Institute for Cancer Research in Montpellier, University of Pennsylvania - Division of Hematology & Oncology, University of Pennsylvania - Division of Hematology & Oncology, Aix-Marseille University, Centre Hospitalier Universitaire (CHU) de Bordeaux - Clinical Hematology Service, Centre Hospitalier Universitaire (CHU) de Bordeaux - Clinical Hematology Service, Centre Hospitalier Universitaire (CHU) de Bordeaux - Biological Hematology Service, Aix-Marseille University - Institut Paoli-Calmettes, MetaboHUB-Paris - Laboratoire d’Etude du Métabolisme des Médicaments, University of Montpellier - Institute for Cancer Research in Montpellier, University of Montpellier - Laboratory of Physical Measurements, National Infrastructure of Metabolomics and Fluxomics - MetaToul-MetaboHUB, Onco-Occitanie Regional Oncology Network, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Montpellier - Institute for Cancer Research in Montpellier, University of Bordeaux - Fruit Biology and Pathology, Aix-Marseille University - Institut Paoli-Calmettes, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), National Infrastructure of Metabolomics and Fluxomics - MetaToul-MetaboHUB, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP) and University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center
Downloads 20
5.

Automated Detection of Acute Lymphocytic Leukemia Using Blast Cell Morphological Features

2nd International Conference on Advances in Science & Technology (ICAST) 2019 on 8th, 9th April 2019 by K J Somaiya Institute of Engineering & Information Technology, Mumbai, India
Number of pages: 6 Posted: 24 Apr 2019
Working Paper Series
Saranathan College of Engineering - Department of Electronics & Communication Engineering (ECE), Saranathan College of Engineering, Students and University of Mumbai - K. J. Somaiya College of Engineering (K.J.S.C.E.)
Downloads 19
6.

Risk of Leukemia after Dengue Virus Infection: A Population-Based Cohort Study

Number of pages: 30 Posted: 18 Apr 2019
Working Paper Series
National Cheng Kung University, National Taiwan University - Division of Radiation Oncology, National Cheng Kung University, National Yang-Ming University - Department of Biomedical Engineering and National Cheng Kung University - Institute of Basic Medical Sciences
Downloads 13
7.

Phase 2 Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes

Number of pages: 41 Posted: 28 Jan 2019
Working Paper Series
University of Florence - MDS Unit, Hospital Vall d’Hebron, Dresden University of Technology - University Clinic Carl Gustav Carus, H. Lee Moffitt Cancer Center and Research Institute, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd - Eli Lilly and Company, Indianapolis, Onkologische Gemeinschaftspraxis, Eli Lilly and Company, Ltd - Eli Lilly and Company, Indianapolis, Eli Lilly and Company, Ltd - Eli Lilly and Company, Indianapolis, Marienhospital, Eli Lilly and Company, Ltd - Eli Lilly and Company, Indianapolis, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd - Eli Lilly and Company, Indianapolis, Montefiore Medical Center, Montefiore Medical Center, Montefiore Medical Center, Montefiore Medical Center, Montefiore Medical Center, Montefiore Medical Center and Montefiore Medical Center
Downloads 9
8.

Rational Response-Adapted Risk Stratification and Treatment for Children with Late Bone Marrow Relapses of B-Cell Precursor Acute Lymphoblastic Leukaemia: A Report from the ALL-REZ BFM Trial Group

Number of pages: 47 Posted: 20 May 2019
Working Paper Series
Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, Goethe University Frankfurt - University Hospital Frankfurt, Heinrich Heine University Dusseldorf - Faculty of Medicine, University of Kiel - University Medical Center, University Medical Center Hamburg-Eppendorf - Clinic of Pediatric Hematology and Oncology, Medical University of Vienna, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology, University Hospital Motol, Medical University of Vienna, University of Zurich, Medical University of Vienna, Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology and Charité - Universitätsmedizin Berlin - Department of Paediatric Oncology and Haematology
Downloads 9
9.

Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia

Number of pages: 46 Posted: 06 Apr 2018
Working Paper Series
St Jude Children’s Research Hospital - Department of Pathology, St Jude Children’s Research Hospital - Department of Pharmaceutical Sciences, University of Padova - Department of Women’s and Children’s Health, Guangzhou Medical University, First Affiliated Hospital, Department of Pediatrics, St Jude Children’s Research Hospital - Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital - Department of Pharmaceutical Sciences, University of Padova - Department of Women’s and Children’s Health, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Shared Resources & Core Facilities, University of Florida - Department of Biostatistics, University of Utah - Huntsman Cancer Institute, MaineHealth - Maine Children's Cancer Program, Duke University - Department of Pediatrics, Cook Children's Medical Center, University of Texas at Dallas - Division of Pediatric Hematology Oncology, Nationwide Children's Hospital - Institute for Genomic Medicine, Washington University in St. Louis - McDonnell Genome Institute, Hannover Medical School - Pediatric Hematology and Oncology, St Jude Children’s Research Hospital - Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital - Department of Pharmaceutical Sciences, St Jude Children’s Research Hospital - Department of Oncology, University of Pennsylvania - Department of Pediatrics, University of California, San Francisco (UCSF) - Department of Pediatrics, University Children's Hospital Tübingen - General Paediatrics, Oncology/Haematology, St Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Pathology and St Jude Children’s Research Hospital - Department of Pharmaceutical Sciences
Downloads 8
10.

Leukocyte Count Trend as an Indicator of Relapse Among Jordanian Leukemia Patients

Number of pages: 10 Posted: 23 May 2016
Working Paper Series
Independent
Downloads 8
11.

Characterization of Three-Way Translocation [t(4;9;22)(p16;q34;q11.2)] in Chronic Myeloid Leukemia

International Journal of Clinical and Experimental Medical Sciences, Vol. 1, No. 2, pp. 30-34, 2015 DOI:10.11648/j.ijcems.20150102.16
Number of pages: 5 Posted: 10 Jul 2017
Accepted Paper Series
S. N. Gene Laboratory and Research Centre - Molecular Cytogenetic Unit, S. N. Gene Laboratory and Research Centre - Molecular Cytogenetic Unit, S. N. Gene Laboratory and Research Centre - Molecular Cytogenetic Unit, S. N. Gene Laboratory and Research Centre - Molecular Cytogenetic Unit and S. N. Gene Laboratory and Research Centre - Molecular Cytogenetic Unit
Downloads 7
12.

A New Compound-ensemble Strategy for Validating Cancer Drug Targets Confirms that Inhibiting Glycolysis Blocks Leukemic Cell Proliferation.

Number of pages: 40 Posted: 04 Apr 2018
Working Paper Series
University of Connecticut - Department of Molecular and Cell Biology, University of Connecticut - Department of Molecular and Cell Biology and University of Connecticut - Department of Molecular and Cell Biology
Downloads 5
13.

Constitutive Activation of BCR Explains Dysfunctional Signaling in Chronic Lymphocytic Leukemia

Number of pages: 58 Posted: 05 Mar 2019
Working Paper Series
Memorial Sloan Kettering Cancer Center - ImmunoDynamics Group, Memorial Sloan Kettering Cancer Center - ImmunoDynamics Group, Memorial Sloan Kettering Cancer Center - Center for Cancer Systems Biology, Memorial Sloan Kettering Cancer Center - ImmunoDynamics Group, Memorial Sloan Kettering Cancer Center - Center for Cancer Systems Biology, Memorial Sloan Kettering Cancer Center - Center for Cancer Systems Biology, Memorial Sloan Kettering Cancer Center - Center for Cancer Systems Biology, National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute and Memorial Sloan Kettering Cancer Center - ImmunoDynamics Group
Downloads 5
14.

Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptors (CAR)-T in Relapsed/Refractory Acute Lymphoblastic Leukemia

Number of pages: 78 Posted: 02 Jan 2019
Working Paper Series
Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Department of Blood Transfusion, Third Military Medical University - Center of Biological Therapy, Third Military Medical University - Center of Haematology and Third Military Medical University - Center of Biological Therapy
Downloads 5
15.

Clonal Evolution in Chronic Lymphocytic Leukemia is Scant in Relapsed But Accelerated in Refractory Cases

CANCER-CELL-D-19-00591
Number of pages: 104 Posted: 11 Jul 2019
Working Paper Series
German Cancer Research Center (DKFZ), University Hospital Ulm, German Cancer Research Center (DKFZ), German Cancer Research Center (DKFZ), University of Zurich, University Hospital Ulm, University Hospital Ulm, University Hospital Ulm, University Hospital Ulm, German Cancer Research Center (DKFZ) and University Hospital Ulm
Downloads 2
16.

Sequential Azacitidine and Lenalidomide for Patients with Relapsed and Refractory Acute Myeloid Leukemia: Clinical Results and Predictive Modeling Using Computational Analysis

Number of pages: 82 Posted: 04 Jan 2019
Working Paper Series
University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Children’s Hospital Colorado, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Children’s Hospital Colorado, University of Colorado at Denver - Children’s Hospital Colorado, University of Colorado at Denver - Children’s Hospital Colorado, Cellworks Group Inc., Cellworks Group Inc., Cellworks Group Inc., University of Florida, University of Florida, University of Colorado at Denver, University of Colorado at Denver - Department of Emergency Medicine, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Division of Hematology and University of Colorado at Denver - Division of Hematology
Downloads 2
17.

Circulating Mir-92a, Mir-143 and Mir-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia

Int J Mol Cell Med. 2017; 6 (2).
Posted: 15 Jun 2017
Accepted Paper Series
Tanta University, School of Pharmacy
18.

Frequency of P-53 Protein Concentration in Chronic Lymphocytic Leukemia

Posted: 18 Mar 2019
Working Paper Series
Titu Maiorescu University - School of Medicine and Pharmacy